investorscraft@gmail.com

Aytu BioPharma, Inc. (AYTU)

Previous Close
$2.39
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)1094.2345780
Intrinsic value (DCF)1.43-40
Graham-Dodd Methodn/a
Graham Formula44.061747

Company Information

373 Inverness Parkway
Englewood, CO 80112
United States
Phone: 720 437 6580
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: Mr. Joshua R. Disbrow
Full Time Employees: 102

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

HomeMenuAccount